Endovia Health Sciences, formerly Splash Beverage, Achieves First FDA Regulatory Milestone for CannEpil® Veterinary Development Program
Endovia Health Sciences (formerly Splash Beverage Group) announced that the FDA has established an Investigational New Animal Drug (INAD) file for its CannEpil® veterinary development program, marking the first regulatory milestone under its collaboration with Lupvindol Biosciences Ltd. The company is developing CannEpil® for cancer-related pain management in companion animals, starting with canine oncology, addressing an unmet medical need as cancer is the leading cause of death in older dogs.